(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202412 | 202312 | % Var | 202412 | 202312 | % Var | 202403 | 202303 | % Var | |
| Sales | 23770.00 | 21230.00 | 11.96 | 72490.00 | 63900.00 | 13.44 | 85330.00 | 76950.00 | 10.89 |
| Other Income | 30.00 | -110.00 | -127.27 | 170.00 | 150.00 | 13.33 | 910.00 | 820.00 | 10.98 |
| PBIDT | 8900.00 | 6900.00 | 28.99 | 27240.00 | 21890.00 | 24.44 | 29810.00 | 25470.00 | 17.04 |
| Interest | 480.00 | 690.00 | -30.43 | 1660.00 | 2360.00 | -29.66 | 3030.00 | 2980.00 | 1.68 |
| PBDT | 8420.00 | 6210.00 | 35.59 | 25580.00 | 19530.00 | 30.98 | 26780.00 | 22490.00 | 19.08 |
| Depreciation | 1910.00 | 1910.00 | 0.00 | 5700.00 | 5660.00 | 0.71 | 7610.00 | 6720.00 | 13.24 |
| PBT | 6510.00 | 4300.00 | 51.40 | 19880.00 | 13870.00 | 43.33 | 19170.00 | 15770.00 | 21.56 |
| TAX | 1660.00 | 1330.00 | 24.81 | 5740.00 | 4400.00 | 30.45 | 5600.00 | 5250.00 | 6.67 |
| Deferred Tax | 410.00 | 580.00 | -29.31 | 1930.00 | 2000.00 | -3.50 | 2380.00 | 2510.00 | -5.18 |
| PAT | 4850.00 | 2970.00 | 63.30 | 14140.00 | 9470.00 | 49.31 | 13570.00 | 10520.00 | 28.99 |
| Equity | 1692.30 | 1692.30 | 0.00 | 1692.30 | 1692.30 | 0.00 | 1692.30 | 1692.30 | 0.00 |
| PBIDTM(%) | 37.44 | 32.50 | 15.20 | 37.58 | 34.26 | 9.69 | 34.93 | 33.10 | 5.55 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1938.85 |
| Dr. Reddys Labs. | 1269.80 |
| Cipla | 1441.70 |
| Zydus Lifesciences | 1159.85 |
| Lupin | 2502.90 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: